Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs

Author： Blumenfeld Zeev  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.7, Iss.6, 2011-11, pp. : 635-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin‐releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta‐analysis

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 51, Iss. 1, 2018-01 ,pp. : 77-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Permanent chemotherapy‐induced nonscarring alopecia and premature ovarian failure

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 5, 2015-07 ,pp. : 589-590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sexual Function in Premature Ovarian Failure

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 3, 2015-03 ,pp. : 685-689

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex

By Wiwanitkit Viroj  

Sexuality and Disability, Vol. 24, Iss. 3, 2006-09 ,pp. : 175-178

Springer Publishing Company

Access to resources Recommend Favorite

Mathematical Model for Gonadotropin Secretion under the Effect of Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Receptor

By Wiwanitkit Viroj  

Sexuality and Disability, Vol. 25, Iss. 1, 2007-03 ,pp. : 41-43

Springer Publishing Company

Access to resources Recommend Favorite